{"entity":{"id":"cprit","kind":"institution","name":"Cancer Prevention and Research Institute of Texas","aka":["CPRIT"],"tldr":"The Texas state agency created by voters in 2007 that is the second-largest public funder of cancer research in the US after the NCI.","summary":"CPRIT was created by a 2007 Texas constitutional amendment authorising $3 billion in bonds for cancer research and prevention, and voters approved a further $3 billion in 2019. It awards academic research grants, recruits scientists to Texas institutions through Scholar awards, funds prevention and screening services in underserved communities and invests in Texas-based cancer companies through its product development programme. CPRIT funding has helped build programmes at MD Anderson, UT Southwestern, Baylor and other Texas centres and has recruited hundreds of investigators to the state. Its oversight committee and peer-review panels are drawn largely from outside Texas.","asOf":"2026-09-09","wikipedia":"https://en.wikipedia.org/wiki/Cancer_Prevention_and_Research_Institute_of_Texas","links":[{"label":"CPRIT","url":"https://www.cprit.texas.gov"},{"label":"Grants","url":"https://www.cprit.texas.gov/grants-funded"}],"tags":[],"related":[],"cancers":[],"sections":["prevention","early-detection","drug-discovery"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["md-anderson","nci"],"pathways":[],"terms":[],"trials":[],"people":["wayne-roberts"],"bottlenecks":["b-funding-allocation","b-workforce","b-translational-valley"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Austin, TX","country":"US","lat":30.267,"lng":-97.743,"institutionType":"government","website":"https://www.cprit.texas.gov","programs":["Academic research grants","Scholar recruitment awards","Prevention and screening services","Product development research (company investments)"]},"route":"/institutions/cprit/","neighbours":{"section":[{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"institution":[{"id":"md-anderson","kind":"institution","name":"MD Anderson Cancer Center","route":"/institutions/md-anderson/"},{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"}],"person":[{"id":"wayne-roberts","kind":"person","name":"Wayne Roberts","route":"/people/wayne-roberts/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-workforce","kind":"bottleneck","name":"Not enough oncologists, nurses, pathologists, physicists","route":"/bottlenecks/b-workforce/"},{"id":"b-translational-valley","kind":"bottleneck","name":"The valley of death between lab and product","route":"/bottlenecks/b-translational-valley/"}],"idea":[{"id":"idea-fund-phase-two-failure-reinsurance","kind":"idea","name":"Government reinsurance for phase 2 failures of first-in-class cancer drugs","route":"/ideas/idea-fund-phase-two-failure-reinsurance/"},{"id":"idea-fund-sovereign-first-in-class-coinvestment","kind":"idea","name":"Public co-investment in first-in-class phase 1 with a royalty return","route":"/ideas/idea-fund-sovereign-first-in-class-coinvestment/"}]}}